Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-02

Clinical Trial Update: Efficacy, Safety and Pharmacokinetics of DTG with RIF [Phase 2]

View source ↗

Summary

This Phase 2 trial is evaluating the efficacy, safety, and pharmacokinetics of dolutegravir with rifampin in people with HIV/TB coinfection and is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rifadin (rifampin)
  • Tivicay (dolutegravir)

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: HIV/TB Coinfection | Phase 2 | Status: RECRUITING